Stimulating effect of some inhibitors of the drug metabolisms (SKF 525 A, Lilly 18947, Lilly 32391 and MG 3062) on excretion of ascorbic acid and drug metabolisms.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000378:metabolism*; D001713:Biphenyl Compounds; D003577:Cytochrome P-450 Enzyme System; D005021:Ethylamines / Q000494:pharmacology*; D006591:Hexobarbital / Q000737:chemistry*; D008620:Meprobamate / Q000378:metabolism*; D009125:Muscle Relaxants, Central / Q000494:pharmacology*; D011335:Proadifen; D013328:Strophanthins / Q000378:metabolism*
D000970:Antineoplastic Agents; D001713:Biphenyl Compounds; D005021:Ethylamines; D009125:Muscle Relaxants, Central; D013328:Strophanthins; C002109:Lilly 18947; D003577:Cytochrome P-450 Enzyme System; D008620:Meprobamate; D011335:Proadifen; D006591:Hexobarbital; D001205:Ascorbic Acid
ANTINEOPLASTIC AGENTS/pharmacology; ETHYLAMINES/pharmacology; HEXOBARBITAL/chemistry; MEPROBAMATE/metabolism; MUSCLE RELAXANTS/pharmacology; STROPHANTHIN/metabolism; VITAMIN C/metabolism